Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

PURPOSE: In the context of prostate cancer (PCa) imaging, the aim of this study was to optimize (in vitro) the specificity and assess preclinically (in vivo) the tumor targeting properties of the (123)I-scFvD2B antibody specific for prostate-specific membrane antigen (PSMA). EXPERIMENTAL DESIGN: The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Frigerio, Barbara, Franssen, Gerben, Luison, Elena, Satta, Alessandro, Seregni, Ettore, Colombatti, Marco, Fracasso, Giulio, Valdagni, Riccardo, Mezzanzanica, Delia, Boerman, Otto, Canevari, Silvana, Figini, Mariangela
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355234/
https://ncbi.nlm.nih.gov/pubmed/28051996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14229
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars